Contribution: Eureka/Eurostar
SignalChem Lifesciences Corporation
$600,000.00
EUREKA Project 15211 EHAV-19 - Engineering of high-affinity soluble Angiotensin Converting Enzyme 2 (ACE2) variants as a treatment for COVID-19
FY 2020-21 · 2020-08-17
Summary
EUREKA Project 15211 EHAV-19 - Engineering of high affinity ACE2 variants as a treatment for Covid-19 with Austrian partner Innophore GmbH.
Department
Program
Eureka/Eurostar
Recipient
Location
Richmond|Richmond, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
818615684
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2021-08-31
Agreement Number
956312
Agreement Start Date
2020-08-17
Agreement Title
EUREKA Project 15211 EHAV-19 - Engineering of high-affinity soluble Angiotensin Converting Enzyme 2 (ACE2) variants as a treatment for COVID-19
Agreement Title (French)
Projet EUREKA 15211 EHAV-19 - Mise au point de variantes de l'enzyme de conversion de l'angiotensine 2 (ACE2) soluble à haute affinité comme traitement contre la COVID-19
Agreement Type
Contribution
Agreement Value
$600,000.00
Amendment Number
0
Coverage
EUREKA is a leading facilitator of innovation, providing a proven platform for international R&D&I cooperation. | EUREKA est un facilitateur de premier plan en innovation, fournissant une plate-forme reconnu pour la coopération internationale en R & D & I.
Description
EUREKA Project 15211 EHAV-19 - Engineering of high affinity ACE2 variants as a treatment for Covid-19 with Austrian partner Innophore GmbH.
Description (French)
Projet EUREKA 15211 EHAV-19 - Mise au point de variantes de l'ACE2 à haute affinité comme traitement contre la Covid-19 avec le partenaire autrichien Innophore GmbH.
Expected Results
Eureka promotes and supports market-oriented international R&D&I project generation, and facilitates access to financing for companies involved in its projects. EUREKA’s strength lies in its well-established international network, connecting 41 full member countries from Europe and 4 associated member countries.
Expected Results (French)
Eureka promouvoit et soutient la génération de projets internationaux de R & D & I axés sur le marché et facilite l'accès au financement pour les entreprises impliquées dans ses projets. La force d'EUREKA réside dans son réseau international bien établi, qui relie 41 pays membres d'Europe et 4 pays membres associés.
Federal Riding
Steveston--Richmond East
Federal Riding (French)
Steveston--Richmond-Est
Federal Riding Number
59031
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Eureka/Eurostar
Program Name (French)
Eureka/Eurostar
Program Purpose
Eureka promotes and supports market-oriented international R&D&I project generation, and facilitates access to financing for companies involved in its projects. EUREKA’s strength lies in its well-established international network, connecting 41 full member countries from Europe and 4 associated member countries.
Program Purpose (French)
Eureka promouvoit et soutient la génération de projets internationaux de R & D & I axés sur le marché et facilite l'accès au financement pour les entreprises impliquées dans ses projets. La force d'EUREKA réside dans son réseau international bien établi, qui relie 41 pays membres d'Europe et 4 pays membres associés.
Recipient Business Number
818615684
Recipient City
Richmond|Richmond
Recipient Country
CA
Recipient Legal Name
SignalChem Lifesciences Corporation
Recipient Operating Name
SLC
Recipient Postal Code
V6V 2J2
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2020-2021-Q2-956312
